Also, among the hub genes of the NAT, SN, and SNAT lists, COL1A2 (12%), KRAS (14%), and VCAN (9%) have a higher mutation rate in tumour samples, respectively (Supplementary Figure 5). This evidence concerns the gene KRAS and neoplasm.